Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison.

"

 Financial disclosures: Kristina F. Galtung certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Financial disclosures:"

"

Financial disclosures: Kristina F. Galtung certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. 

Funding/Support and role of the sponsor: None."

"The PROspective Trial for Examining Hematuria using Computed Tomography (PROTEHCT) was a single-centre, prospective, noninferiority, paired comparison of two CT protocols for assessing UC, RCC, and urinary stone disease in patients with VH. All patients signed a letter of consent, and the study was approved by the regional ethics committee (2019/395) and registered at ClinicalTrials.gov (NCT04077359). In this first paper, we report the results for UC. The results for RCC and stone disease will be reported in separate papers."